Stay updated on Surufatinib & JS001 Combo in Advanced Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Surufatinib & JS001 Combo in Advanced Solid Tumors Clinical Trial page.

Latest updates to the Surufatinib & JS001 Combo in Advanced Solid Tumors Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe page now shows Revision: v3.6.5, replacing Revision: v3.6.4, indicating a platform update. This change does not affect the study details or other visible content.SummaryDifference0.1%

- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedRevision label was updated from v3.6.3 to v3.6.4, indicating a new build of the page. This update does not modify the study information or how the page functions.SummaryDifference0.1%

- Check51 days agoChange DetectedRevision label changed from v3.6.2 to v3.6.3, signaling a system or UI update. No study content, eligibility criteria, or results were altered.SummaryDifference0.1%

- Check58 days agoChange DetectedThe page’s revision tag was updated from v3.6.0 to v3.6.2, signaling an update to the study record since the prior version.SummaryDifference0.1%

- Check72 days agoChange DetectedThe page’s Study Details metadata and labels have been updated to include the investigator’s name and verification status, and to standardize the treatment-related heading.SummaryDifference2%

- Check79 days agoChange DetectedThe page revision tag was updated from v3.5.4 to v3.5.5, representing a minor page refresh with no change to the study details.SummaryDifference0.1%

Stay in the know with updates to Surufatinib & JS001 Combo in Advanced Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Surufatinib & JS001 Combo in Advanced Solid Tumors Clinical Trial page.